Urology Partnerships The at-home prostate cancer screening approach positions Gregor Diagnostics for pilots with urology clinics and men’s health programs, enabling real world validation and payer discussions. Target midwest health systems and academic medical centers first to establish reimbursement pathways and clinician adoption, leveraging the credibility from the scientific advisory board.

Industry Allies The presence of established diagnostics players in the space signals opportunities for distribution, licensing, or co development with larger partners to scale manufacturing, regulatory support, and market access.

Academic & Grants Historical WARF collaboration and ongoing academic links offer avenues for joint clinical validation studies, government grants, and multi site trials that can de risk regulatory approval and accelerate adoption.

Supply Chain Seminal fluid based screening requires specialized collection kits and logistics; partnering with kit manufacturers and logistics providers can create a reliable end to end supply chain for pilots and early deployments.

Data Platform The cloud oriented tech stack enables a secure physician portal and results management; positioning a HIPAA compliant data platform with EHR and telehealth integrations can be a differentiator in program deployments and payer negotiations.